World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
28489
World Ranking
14538
National Ranking
7357

Overview

Samuel A. Wells is affiliated with the National Cancer Institute in the United States. Their research spans multiple fields, including Agricultural and Biological Sciences and Medicine, with significant contributions across several subfields such as Ecology, Evolution, Behavior and Systematics, Paleontology, Epidemiology, Neurology, and Endocrinology, Diabetes and Metabolism.

Wells has actively contributed to topics including:

  • Coleoptera Taxonomy and Distribution
  • Scarabaeidae Beetle Taxonomy and Biogeography
  • Coleoptera: Cerambycidae studies
  • Neuroendocrine Tumor Research Advances
  • Neuroblastoma Research and Treatments
  • Pituitary Gland Disorders and Treatments
  • Plant and animal studies

The scientist has published in diverse academic venues, with appearances in:

  • The Coleopterists Bulletin
  • Annals of Surgical Oncology
  • World Journal of Surgery
  • Western North American Naturalist

Selected recent publications include:

  • "A Nomenclatural Summary of North American Zorochros Thomson (Coleoptera: Elateridae), with Two Species Transfers" (2021) in The Coleopterists Bulletin
  • "Jeffrey A. Norton and the Multiple Endocrine Neoplasia Syndromes" (2024) in Annals of Surgical Oncology
  • "Issue Information" (2024) in World Journal of Surgery
  • "Insects Associated with Welsh's Milkweed (Asclepias welshii) at Coral Pink Sand Dunes State Park, Utah" (2025) in Western North American Naturalist

Frequent collaborators in Wells's work include Paul J. Johnson, Larry Hadley, Julie Hallet, Zane T. Hammoud, and Kiyoshi Hasegawa.

In addition to journal articles, Wells has authored a book published by Cambridge University Press titled Constructing an Incarnational Theology (2025).

Best Publications

  • CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

    Maria Luisa Brandi;Robert F. Gagel;Alberto Angeli;John P. Bilezikian

  • Medullary thyroid cancer: management guidelines of the American Thyroid Association.

    Richard T. Kloos;Charis Eng;Douglas B. Evans;Gary L. Francis

  • Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC

    Helen Donis-Keller;Shenshen Dou;David Chi;Katrin M. Carlson

  • Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

    Samuel A. Wells;Bruce G. Robinson;Robert F. Gagel;Henning Dralle

  • Biologic and Clinical Perspectives on Thyroid Cancer

    James A. Fagin;Samuel A. Wells

  • Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.

    Katrin M. Carlson;Shenshen Dou;David Chi;Nancy Scavarda

  • Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

    Samuel A. Wells;Jessica E. Gosnell;Robert F. Gagel;Jeffrey Moley

  • Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.

    Samuel A. Wells;David D. Chi;Koji Toshima;Louis P. Dehner

  • Transplantation of the parathyroid glands in man: clinical indications and results.

    Wells Sa;Gunnells Jc;Shelburne Jd;Schneider Ab

  • Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.

    Michael A. Skinner;Jeffrey A. Moley;William G. Dilley;Kouros Owzar

  • The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS Mutations

    Chan Kwon Jung;Chan Kwon Jung;Mark P. Little;Jay H. Lubin;Alina V. Brenner

  • Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity.

    J. R. Farndon;G. S. Leightt;W. G. Dilley;S. B. Baylin

  • Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up.

    John A. Olson;Mary K. DeBenedetti;Dirk S. Baumann;Samuel A. Wells

  • Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update

    Samuel A. Wells;Furio Pacini;Bruce G. Robinson;Massimo Santoro

  • Lethality of Multiple Endocrine Neoplasia Type I

    Gerard M. Doherty;John A. Olson;Margaret M. Frisella;Terry C. Lairmore

  • Parent-of-origin effects in multiple endocrine neoplasia type 2B.

    Katrin M. Carlson;John Bracamontes;Charles E. Jackson;Robin Clark

  • Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland.

    Samuel Wells;Stephen Baylin;W. Linehan;Ruth Farrell

  • A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast Cancer

    Richard J. Santen;Thomas J. Worgul;Eugeniusz Samojlik;Albert Interrante

  • Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference.

    Keiser Hr;Beaven Ma;Doppman J;Wells S

  • Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes

    Terry C. Lairmore;Douglas W. Ball;Stephen B. Baylin;Samuel A. Wells

Frequent Co-Authors

Paul J. Goodfellow
Paul J. Goodfellow The Ohio State University
Jeffrey A. Norton
Jeffrey A. Norton Stanford University
Helen Donis-Keller
Helen Donis-Keller Washington University in St. Louis
Stephen B. Baylin
Stephen B. Baylin Johns Hopkins University
Michael J. Welch
Michael J. Welch Washington University in St. Louis
Stephen J. Marx
Stephen J. Marx National Institutes of Health
Gerard M. Doherty
Gerard M. Doherty Brigham and Women's Hospital
Allan Lipton
Allan Lipton Penn State Milton S. Hershey Medical Center
Joseph M. Davie
Joseph M. Davie Pfizer (Germany)
John L. Doppman
John L. Doppman National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare careers and degree pathways can open new doors for aspiring medical professionals. For students who want to transition quickly into nursing, there are online MSN programs for non nurses that offer a direct entry into advanced practice without traditional prerequisites.

Entry requirements vary widely across institutions. Some are sought after for being what's the easiest nursing program to get into?, providing accessible options for those looking to join the field with less competitive admissions.

Not all healthcare roles require years of extensive training. If you’re interested in a fast-growing administrative area, consider online medical billing and coding schools that accept fafsa, which can lead to stable and in-demand careers with flexible study options and potential financial aid.

For those concerned about standardized testing, several nursing schools that don't require teas test are available online and offline, making it easier for applicants to start their journey without extra exam stress.

Best Scientists Citing Samuel A. Wells

Trending Scientists